The European Steering Group (ESG) on Sustainable Healthcare was initiated in March 2014, in the framework of the initiative “Recipes for Sustainable Healthcare”, created in May 2013 under the leadership of the biopharmaceutical company AbbVie, in close partnership with Philips and the European Public Health Association (EPHA). As of today, this multi-stakeholder partnership has extended to include also the European Patients Forum (EPF).
With representatives from the policy environment and civil society, healthcare professionals and scientific societies, academics, and industry, ESG provide insight and expertise based on evidence and tested examples which can help address the challenges posed to European healthcare systems.
The group, chaired by Mary Harney, former Health Minister of Ireland, meets regularly and organises roundtable meetings with high-level policy stakeholders at EU level, including the European Commission, the Council of the EU and the European Parliament. The group also has close exchanges with key policy stakeholders from Member States.
The objective of ESG is to advocate, through concrete actions and projects, the means to transform our healthcare systems to be more sustainable.
Address: Grayling, 46 Avenue des Arts, 1000 Brussels
Tel.: +32 2 732 70 40
Email: esg-secretariat@grayling.com
Website: http://sustainable-healthcare.abbvie.com/
Mary Harney, Chairperson of the European Steering Group (ESG) on Sustainable Healthcare, outlines the mandate and activities of the Group, the financial tsunami that European healthcare systems face and the…
Recent announcements from Ipsen and AbbVie of multimillion Euro investments into Irish manufacturing plants underline the Celtic nation’s continuing attractiveness to pharma multinationals. While an upcoming hike in Ireland’s famously…
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million manufacturing investment; and a new report on…
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key priorities of their exciting new Mercury 2021 strategy, the rationale behind their transition into…
David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life Sciences at Agility, discuss the company’s increased commitment to Ireland, their ongoing…
Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market, and more broadly in Ireland, during her extensive career at PwC.…
These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with increasing global demand for its products. “Sales from…
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s…
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory solutions, discusses the changes that the Irish healthcare system is going through, and how they…
Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help the pharmaceutical industry increase efficiency and save costs through their agile,…
Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly in North America, across both their Sharp and Ashfield business units. He also expands on…
Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve years, their comprehensive pain portfolio, the innovation they are bringing as pain specialists to…
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles…
See our Cookie Privacy Policy Here
